Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis
US10426758B2 · kind B2 · utility
0Cited by
1References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 13, 2016 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | Oct 13, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of the following general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as inhibitor of cellular necroptosis. The present invention also relates to a pharmaceutical composition comprising a compound of general formula (I), or a pharmaceutically acceptable salt and/or solvate thereof, for use for preventing and/or treating disorders associated with cellular necroptosis. The present invention also encompasses the use of a compound of the general formula (I) for organs preservation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.